Do I need an in-person exam for Wegovy in New York?

If you’ve been considering medications like Wegovy, Ozempic, or Mounjaro for weight loss, you’ve probably wondered: Can I actually get these prescriptions through telehealth? The short answer is yes—and for most people, it’s easier and more accessible than you might think.

With obesity affecting over 40% of American adults and revolutionary GLP-1 medications showing remarkable results, telehealth has become a game-changer in weight management. But navigating the patchwork of federal and state regulations can feel overwhelming. This guide breaks down everything you need to know about accessing weight loss medications through virtual care in 2025.

Understanding the Legal Landscape: Federal Rules Made Simple

Here’s the good news: Federal law does not require an in-person visit before prescribing GLP-1 weight loss medications like Wegovy, Ozempic, or Mounjaro.

Why? These medications are not controlled substances. The Ryan Haight Act—which typically mandates in-person exams for certain prescriptions—only applies to controlled drugs like Adderall or opioids. Since semaglutide and tirzepatide fall outside this category, healthcare providers can legally prescribe them after a comprehensive telehealth evaluation.

During the COVID-19 pandemic, the DEA relaxed telehealth prescribing rules even for controlled substances. Those flexibilities have been extended through December 31, 2025, making virtual healthcare more accessible than ever. While this extension primarily affects medications like ADHD treatments or pain management drugs, it reflects a broader regulatory shift toward embracing telemedicine.

Bottom line: For weight loss medications specifically, telehealth prescribing has always been permissible under federal law—and it’s not going anywhere.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

State-by-State Variations: What You Need to Know

While federal law provides the foundation, individual states add their own requirements. Some states embrace telehealth with minimal restrictions, while others require additional steps to ensure patient safety.

States with Minimal Restrictions

California, Washington, New York, Illinois, and Pennsylvania lead the pack with telehealth-friendly policies. In these states, you can:

• Complete your entire evaluation via video consultation
• Receive your prescription electronically
• Never set foot in a physical office (unless you choose to)

Providers in these states must still conduct thorough medical assessments, review your health history, and establish a legitimate patient-provider relationship—but they can accomplish all of this virtually.

States Requiring Initial In-Person Visits

Arkansas, Delaware, Georgia, Mississippi, New Jersey, South Carolina, and Texas typically require at least one in-person examination before or shortly after beginning telehealth weight loss treatment.

For example:

• Georgia mandates an initial physical exam before prescribing weight loss medications via telehealth
• New Jersey requires comprehensive baseline evaluation including physical exam, laboratory work, and psychological screening
• Texas generally expects an in-person assessment as part of establishing the standard of care for obesity treatment

States with Special Requirements

Florida permits telehealth prescribing but adds specific conditions:

• Patients must have a BMI of 30 or higher (or 27+ with weight-related health conditions)
• Follow-up appointments are required at least every 3 months during treatment
• Treatment plans must include lifestyle modification counseling

Virginia requires:

• Initial comprehensive physical examination and laboratory testing
• A personalized diet and exercise plan
• Follow-up within 30 days of starting medication

Connecticut mandates that obesity treatment include behavioral counseling alongside medication.

These requirements aren’t meant to create barriers—they’re designed to ensure you receive comprehensive, safe care that addresses the root causes of weight management challenges.

Who Can Prescribe Weight Loss Medications Via Telehealth?

Physicians (MD/DO)

Licensed medical doctors and doctors of osteopathic medicine can prescribe GLP-1 medications in all states via telehealth, provided they hold an active license in the state where you’re located during the consultation.

Nurse Practitioners (NPs)

The ability for NPs to prescribe independently varies significantly by state:

Full Independent Practice (34 states + DC as of 2025):

• California, Washington, New York, Arizona, Oregon, Utah, and others
• NPs can evaluate, diagnose, and prescribe without physician oversight
• After meeting experience requirements (typically 2-3 years), NPs practice autonomously

Collaborative Practice (remaining states):

• Texas, Florida, Georgia, Pennsylvania, and others
• NPs must maintain agreements with supervising physicians
• Can still prescribe GLP-1 medications with proper physician collaboration

Physician Assistants (PAs)

PAs can prescribe weight loss medications in all states, though they typically work under physician supervision or collaboration agreements. The level of autonomy varies by state.

Important note: Regardless of your provider type, legitimate telehealth services like Klarity Health ensure all clinicians are properly licensed, credentialed, and authorized to prescribe in your specific state.

The Medications: What You Can Actually Get Through Telehealth

Wegovy (Semaglutide 2.4mg)

FDA Status: Approved specifically for chronic weight management
Typical Patient Profile: Adults with BMI ≥30, or ≥27 with weight-related conditions
Telehealth Availability: ✅ Fully available in all states (subject to state-specific requirements)

Wegovy is the gold-standard FDA-approved option for obesity treatment. Prescribers will evaluate whether you meet clinical criteria and can safely use this medication.

Ozempic (Semaglutide 0.5-1mg)

FDA Status: Approved for Type 2 diabetes; used off-label for weight loss
Typical Patient Profile: Patients with diabetes, or those seeking weight loss when Wegovy is unavailable
Telehealth Availability: ✅ Available, but requires off-label documentation

Ozempic contains the same active ingredient as Wegovy but at different doses. Reputable telehealth providers will discuss the off-label use, obtain informed consent, and ensure you understand both benefits and risks.

Mounjaro/Zepbound (Tirzepatide)

FDA Status: Mounjaro approved for diabetes; Zepbound approved for weight loss
Typical Patient Profile: Adults meeting obesity criteria, especially those who haven’t achieved goals with other medications
Telehealth Availability: ✅ Fully available

Tirzepatide represents the newest class of weight loss medication, showing even more impressive results in clinical trials than semaglutide alone.

What to Expect During Your Telehealth Weight Loss Consultation

Legitimate telehealth weight loss programs follow rigorous protocols to ensure your safety:

1. Comprehensive Medical History

You’ll complete a detailed questionnaire covering:

• Current medications and supplements
• Past and current medical conditions
• Previous weight loss attempts
• Family history of thyroid cancer or other contraindications
• Psychological health and eating behaviors

2. Virtual Physical Assessment

During your video consultation, your provider will:

• Verify your current weight and height (you may need to demonstrate weighing yourself)
• Calculate your BMI
• Discuss your weight loss goals and realistic expectations
• Review any recent laboratory work or order new tests if needed
• Screen for contraindications (pregnancy plans, history of pancreatitis, gallbladder disease)

3. Personalized Treatment Plan

Your provider will create a comprehensive plan that includes:

• Medication selection and dosing schedule
• Lifestyle modification strategies (nutrition, exercise)
• Expected timeline and weight loss goals
• Potential side effects and how to manage them
• Follow-up schedule

4. Informed Consent

You’ll receive detailed information about:

• How the medication works
• Common side effects (nausea, digestive changes, etc.)
• Serious but rare risks (thyroid tumors, pancreatitis, gallstones)
• The importance of combining medication with lifestyle changes
• Cost considerations and insurance coverage

5. Prescription and Pharmacy Coordination

If approved, your prescription will be sent electronically to your preferred pharmacy. Many telehealth providers like Klarity Health can help coordinate with pharmacies to find the best pricing and availability.

Safety First: Red Flags to Avoid

The popularity of weight loss medications has unfortunately attracted some questionable operators. Protect yourself by avoiding services that:

❌ Guarantee prescriptions without evaluation – Legitimate providers assess each patient individually and may determine medication isn’t appropriate for you

❌ Offer compounded versions of name-brand drugs – The FDA banned most compounded semaglutide in May 2025 due to safety concerns. Stick with FDA-approved medications from licensed pharmacies

❌ Skip follow-up appointments – Responsible care requires ongoing monitoring, dose adjustments, and safety checks

❌ Aren’t transparent about provider credentials – You should know exactly who’s prescribing your medication and verify they’re licensed in your state

❌ Pressure you to start immediately – Good providers give you time to consider options, ask questions, and make informed decisions

❌ Minimize risks or make unrealistic promises – Anyone claiming ‘lose 50 pounds in 2 months’ or ‘no side effects’ isn’t being honest about how these medications work

The Cost Factor: Insurance, Cash Pay, and Transparency

Insurance Coverage

Insurance coverage for GLP-1 weight loss medications varies widely:

• Some plans cover Wegovy when prescribed for obesity with documentation of failed diet/exercise attempts
• Coverage often requires prior authorization and step therapy
• Copays can range from $25 to several hundred dollars monthly

Cash Pay Options

When insurance doesn’t cover treatment:

• Name-brand medications can cost $1,000-$1,300 per month without insurance
• Telehealth providers may negotiate better pricing
• Patient assistance programs and manufacturer coupons can significantly reduce costs

Klarity Health accepts both insurance and cash pay, providing transparent pricing upfront so you can make informed financial decisions about your care. Our team helps navigate insurance authorization processes and explores cost-saving options.

Follow-Up Care: The Key to Long-Term Success

Weight loss medications aren’t a quick fix—they’re tools that work best with ongoing support and monitoring.

Typical Follow-Up Schedule:

• First month: Check-in at 2-4 weeks to assess tolerance and side effects
• Months 2-6: Monthly or bi-monthly visits to adjust dosing and monitor progress
• After 6 months: Quarterly check-ins if treatment is stable and effective

During follow-ups, your provider will:

• Track weight loss progress and adjust expectations if needed
• Titrate medication dosing for optimal results
• Review and manage side effects
• Order periodic lab work (metabolic panel, liver function)
• Reinforce lifestyle modifications
• Assess whether continued treatment remains appropriate

Some states mandate specific follow-up frequencies—Florida requires at least one visit every 3 months, while Virginia requires a check-in within 30 days of starting medication.

The Future of Telehealth Weight Loss Treatment

Telehealth for obesity treatment isn’t a temporary pandemic phenomenon—it’s the new standard of care. Here’s what’s on the horizon:

Expanding Access

• More states are adopting full practice authority for nurse practitioners
• Interstate licensure compacts are making it easier for providers to treat patients across state lines
• Legislative efforts like the TREATS Act could further streamline telehealth prescribing

Improved Insurance Coverage

• Growing recognition of obesity as a chronic disease is driving better insurance coverage
• Medicare coverage expansion is under consideration
• More employers are adding weight management benefits

New Medications

• Additional GLP-1 and dual-agonist medications are in development
• Oral versions of these medications are in clinical trials
• Combination therapies may offer even better results

Enhanced Technology

• Remote monitoring devices can track weight, activity, and vital signs
• AI-powered nutrition coaching integrated with medication management
• Virtual support groups and behavioral health integration

Making the Right Choice for Your Weight Loss Journey

Telehealth provides unprecedented access to effective weight loss medications—but it’s not right for everyone, and medication alone isn’t a complete solution.

Telehealth weight loss treatment may be ideal if you:

• Have a BMI of 30 or higher (or 27+ with weight-related health conditions)
• Have attempted lifestyle changes without sufficient results
• Want convenience and privacy in your healthcare
• Live in areas with limited access to obesity specialists
• Prefer ongoing virtual support over in-person appointments

You should consider in-person care if:

• You have complex medical conditions requiring hands-on examination
• Your state requires initial in-person evaluation and you prefer to stay local
• You’re more comfortable with traditional face-to-face medical relationships
• You need procedures or treatments beyond medication management

Klarity Health: Your Partner in Accessible Weight Management

At Klarity Health, we believe effective weight loss treatment should be accessible, affordable, and built on clinical excellence. Our telehealth platform connects you with licensed medical providers who specialize in obesity medicine and understand the complexities of weight management.

What sets Klarity apart:

✓ Licensed Providers in Your State – Our network includes physicians and nurse practitioners credentialed in all the states we serve, ensuring compliance with your local regulations

✓ Comprehensive Evaluations – We don’t just hand out prescriptions. Every patient receives a thorough assessment and personalized treatment plan

✓ Transparent Pricing – Know exactly what you’ll pay upfront, whether using insurance or cash

✓ Insurance and Cash Pay Options – We work with major insurance plans and offer competitive self-pay rates

✓ Ongoing Support – Regular follow-ups, medication management, and lifestyle coaching keep you on track

✓ Provider Availability – Get appointments quickly, with evening and weekend options available

✓ Privacy and Convenience – Access care from home, without judgment or the hassle of waiting rooms

Take the First Step Today

Weight loss is a journey, not a destination—and you don’t have to walk that path alone. Telehealth has made evidence-based obesity treatment more accessible than ever before, bringing expert care directly to you regardless of where you live.

If you’re struggling with your weight and traditional approaches haven’t worked, GLP-1 medications prescribed through telehealth might be the tool you need to finally achieve lasting results. Combined with lifestyle changes and ongoing medical support, these medications have helped millions of people transform their health.

Ready to explore your options? Schedule a consultation with Klarity Health today to speak with a licensed provider who can assess your unique situation and determine if weight loss medication is right for you. Our team is here to answer your questions, navigate insurance coverage, and support you every step of the way.

Your healthier future is just a video call away.

References and Sources

1. DEA and HHS Extend Telemedicine Flexibilities through 2025 – Official DEA announcement confirming extension of teleprescribing flexibilities through December 31, 2025. www.dea.gov

2. ‘COVID-era telehealth prescribing extended for Adderall, other drugs’ – Axios News, November 18, 2024. Comprehensive coverage of the DEA’s third extension of pandemic-era telehealth flexibilities. www.axios.com

3. ‘DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing Through December 31, 2025’ – McDermott Will & Emery legal analysis, November 18, 2024. Expert legal interpretation of federal telehealth regulations and their implications. www.mwe.com

4. ‘The Changing Regulatory and Reimbursement Landscape for Weight-Loss Drugs’ – Goodwin Procter client alert, March 27, 2024. Detailed analysis of state-specific regulations for obesity medications including Florida, New Jersey, and Virginia requirements. www.goodwinlaw.com

5. ‘Know Your State’s Laws Around Semaglutide’ – Nextech healthcare blog, April 11, 2025. State-by-state compilation of prescribing requirements and in-person examination rules for weight loss medications. www.nextech.com

Research Currency Statement
Verified as of: December 17, 2025
All information current as of publication date. Federal telehealth flexibilities for controlled substances remain in effect through December 31, 2025. State regulations subject to change; readers should verify current requirements in their specific state before seeking treatment.

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid